Less common but important other side effects include kidney disease and gallbladder issues, while severe risks may include pancreatitis and gallbladder disease
No, insomnia is not listed as a documented adverse effect in UK regulatory data or clinical trials
What the FDA Has Said About BPC-157 and Compounding In September 2023, the FDA put BPC-157 in Category 2 of the 503A Interim Bulks Guidance, which stopped pharmacies from compounding it
10.3389/fendo.2020.00267 Front Endocrinol
1, 2, 3...ready, set, glow
At full doses, some studies found that these medications may influence aging at both a cellular and systemic level by improving metabolic efficiency, reducing inflammation and shielding the body from the biological stressors that accelerate age-related decline